Janssen Search
Search results
The Importance Of Workplace Diversity
Why Having a Diverse and Harmonious Workplace is More Important Than Ever As the Asia Pacific region continues to accelerate economically and evolve demographically, organizations are increasingly monitoring whether their workforces reflect the diverse ...
Janssen at CROI: Harnessing Innovation in HIV Therapeutics
Janssen at CROI: Harnessing Innovation in HIV Therapeutics HIV remains one the biggest public health threats of our time. It is estimated that 36.7 million people are currently living with HIV globally, with at least 1.8 million more becoming newly ...
One Size Fits Not: The "E's" of Accessible Transformational Medicines for Those Living with Rare Diseases
One Size Fits Not: The "E's" of Accessible Transformational Medicines for Those Living with Rare Diseases Did you know that approximately 300 million people worldwide are living with one of the 6,000+ rare diseases, most of which have no ...
Providing Patients with Prostate Cancer and Blood Cancer More Time
Providing Patients with Prostate Cancer and Blood Cancer More Time September is Prostate Cancer and Blood Cancer Awareness Month, and while these diseases may not seem to have much in common, in fact they share inseparable characteristics. Despite ...
BIO-Europe Spring 2019
The 13th annual BIO-Europe Spring 2019 will take place March 25–27, 2019, in Vienna, Austria. The conference brings together hundreds of the world’s most innovative leaders across biotech, finance and pharma for high-level networking, pre-scheduled ...
BIO-Europe Spring 2021
The 15th annual BIO-Europe Spring 2021 will take place virtually March 22–25. The conference brings together hundreds of the world’s most innovative leaders across biotech, finance and pharma for high-level networking, pre-scheduled partnering meetings, ...
Recognizing World Arthritis Day 2017
Recognizing World Arthritis Day 2017 For more than three decades, Janssen Immunology has been focused on innovating for patients, because we understand the impact rheumatic diseases have on individuals, and their families, friends and loved ones. The ...
Prostate Cancer
Prostate Cancer Janssen has built a legacy of innovation in the treatment of prostate cancer, the second most common cancer in men worldwide. We have developed a novel agent for patients with metastatic castration-resistant prostate cancer (mCRPC) and, ...
Careers with Janssen Immunology
Welcome, we're glad you're here! Our mission is to redefine treatments for immune diseases by delivering transformational and accessible therapies and regimens to patients. To get there, we need to push the boundaries of science and creativity – ...
Oncology Affiliates
Our Affiliates in Oncology Considering oncology patients at every stage of their journey We facilitate scientific interchange and collaboration among our extensive worldwide family of companies. The decentralized business model of the Johnson & ...